159 related articles for article (PubMed ID: 14670176)
1. SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma.
Zimonjic DB; Durkin ME; Keck-Waggoner CL; Park SW; Thorgeirsson SS; Popescu NC
Neoplasia; 2003; 5(5):390-6. PubMed ID: 14670176
[TBL] [Abstract][Full Text] [Related]
2. Increased CYP3A4 copy number in TONG/HCC cells but not in DNA from other humans.
Lamba JK; Chen X; Lan LB; Kim JW; Wei Wang X; Relling MV; Kazuto Y; Watkins PB; Strom S; Sun D; Schuetz JD; Schuetz EG
Pharmacogenet Genomics; 2006 Jun; 16(6):415-27. PubMed ID: 16708050
[TBL] [Abstract][Full Text] [Related]
3. Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60.
Zavadil J; Brezinová J; Svoboda P; Zemanová Z; Michalová K
Leukemia; 1997 Aug; 11(8):1187-92. PubMed ID: 9264367
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the expression of Bin1, a putative suppressor, in human hepatoma cells.
Livezey KW; Negorev D; Simon D
Cancer Genet Cytogenet; 2000 Jan; 116(1):35-9. PubMed ID: 10616529
[TBL] [Abstract][Full Text] [Related]
5. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
Patil MA; Gütgemann I; Zhang J; Ho C; Cheung ST; Ginzinger D; Li R; Dykema KJ; So S; Fan ST; Kakar S; Furge KA; Büttner R; Chen X
Carcinogenesis; 2005 Dec; 26(12):2050-7. PubMed ID: 16000397
[TBL] [Abstract][Full Text] [Related]
6. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma.
Park SW; Ludes-Meyers J; Zimonjic DB; Durkin ME; Popescu NC; Aldaz CM
Br J Cancer; 2004 Aug; 91(4):753-9. PubMed ID: 15266310
[TBL] [Abstract][Full Text] [Related]
7. Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.
Yung MK; Lo KW; Yip CW; Chung GT; Tong CY; Cheung PF; Cheung TT; Poon RT; So S; Fan ST; Cheung ST
BMC Cancer; 2015 Apr; 15():264. PubMed ID: 25885205
[TBL] [Abstract][Full Text] [Related]
8. An antisense transcript to SMAD5 expressed in fetal and tumor tissues.
Zavadil J; Svoboda P; Liang H; Kottickal LV; Nagarajan L
Biochem Biophys Res Commun; 1999 Feb; 255(3):668-72. PubMed ID: 10049768
[TBL] [Abstract][Full Text] [Related]
9. Nonrandom breakpoints of unbalanced chromosome translocations in human hepatocellular carcinoma cell lines.
Keck CL; Zimonjic DB; Yuan BZ; Thorgeirsson SS; Popescu NC
Cancer Genet Cytogenet; 1999 May; 111(1):37-44. PubMed ID: 10326589
[TBL] [Abstract][Full Text] [Related]
10. Parkin gene alterations in hepatocellular carcinoma.
Wang F; Denison S; Lai JP; Philips LA; Montoya D; Kock N; Schüle B; Klein C; Shridhar V; Roberts LR; Smith DI
Genes Chromosomes Cancer; 2004 Jun; 40(2):85-96. PubMed ID: 15101042
[TBL] [Abstract][Full Text] [Related]
11. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis.
Bruno E; Horrigan SK; Van Den Berg D; Rozler E; Fitting PR; Moss ST; Westbrook C; Hoffman R
Blood; 1998 Mar; 91(6):1917-23. PubMed ID: 9490674
[TBL] [Abstract][Full Text] [Related]
12. EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma.
Yasui K; Konishi C; Gen Y; Endo M; Dohi O; Tomie A; Kitaichi T; Yamada N; Iwai N; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Tanaka S; Arii S; Itoh Y
Cancer Sci; 2015 Jul; 106(7):929-37. PubMed ID: 25959919
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia.
Jiang Y; Liang H; Guo W; Kottickal LV; Nagarajan L
Blood; 2000 Jun; 95(12):3945-50. PubMed ID: 10845932
[TBL] [Abstract][Full Text] [Related]
14. NOXIN as a cofactor of DNA polymerase-primase complex could promote hepatocellular carcinoma.
Zhang ZZ; Huang J; Wang YP; Cai B; Han ZG
Int J Cancer; 2015 Aug; 137(4):765-75. PubMed ID: 25612832
[TBL] [Abstract][Full Text] [Related]
15. Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.
Yuan BZ; Zhou X; Zimonjic DB; Durkin ME; Popescu NC
J Mol Diagn; 2003 Feb; 5(1):48-53. PubMed ID: 12552080
[TBL] [Abstract][Full Text] [Related]
16. PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues.
Tantiwetrueangdet A; Panvichian R; Sornmayura P; Leelaudomlipi S; Macoska JA
BMC Cancer; 2021 Mar; 21(1):295. PubMed ID: 33743635
[TBL] [Abstract][Full Text] [Related]
17. Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver.
Sargent LM; Zhou X; Keck CL; Sanderson ND; Zimonjic DB; Popescu NC; Thorgeirsson SS
Am J Pathol; 1999 Apr; 154(4):1047-55. PubMed ID: 10233843
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4.
Fuchs O; Simakova O; Klener P; Cmejlova J; Zivny J; Zavadil J; Stopka T
Blood Cells Mol Dis; 2002; 28(2):221-33. PubMed ID: 12064918
[TBL] [Abstract][Full Text] [Related]
19. Infrequent amplification of JUN in hepatocellular carcinoma.
Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
[TBL] [Abstract][Full Text] [Related]
20. Generation of a floxed allele of Smad5 for cre-mediated conditional knockout in the mouse.
Umans L; Vermeire L; Francis A; Chang H; Huylebroeck D; Zwijsen A
Genesis; 2003 Sep; 37(1):5-11. PubMed ID: 14502571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
